Congress Wealth Management’s Neogen NEOG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-12,271
Closed -$206K 905
2024
Q3
$206K Buy
+12,271
New +$202K ﹤0.01% 816
2023
Q4
Sell
-172,041
Closed -$3.19M 649
2023
Q3
$3.19M Buy
172,041
+10,627
+7% +$231K 0.07% 261
2023
Q2
$3.51M Buy
161,414
+316
+0.2% +$5.71K 0.08% 223
2023
Q1
$2.98M Buy
161,098
+44,566
+38% +$838K 0.07% 234
2022
Q4
$1.77M Sell
116,532
-40,214
-26% -$573K 0.05% 274
2022
Q3
$2.19M Buy
156,746
+20,771
+15% +$418K 0.06% 266
2022
Q2
$3.28M Buy
135,975
+6,261
+5% +$168K 0.08% 233
2022
Q1
$4M Buy
129,714
+26,630
+26% +$957K 0.09% 232
2021
Q4
$4.68M Buy
+103,084
New +$4.41M 0.09% 232

Other funds holding NEOG

Congress Wealth Management's NEOG Position: Q4 2024 in Review

Congress Wealth Management sold out of Neogen (NEOG) in Q4 2024, closing a stake of 12,271 shares — an estimated $206K sold.

Congress Wealth Management first reported a position in NEOG in Q4 2021 and held it in 9 quarters. The position peaked at $4.68M in Q4 2021. 343 funds tracked by Wall St. Rank hold NEOG as of Q4 2024.

  • Congress Wealth Management reported no remaining Neogen position as of Q4 2024 after selling out during the quarter.
  • Congress Wealth Management sold 12,271 Neogen shares in Q4 2024, an estimated $206K.
  • Congress Wealth Management first reported a position in Neogen in Q4 2021 and held it in 9 quarters.
  • Congress Wealth Management's Neogen position peaked at $4.68M in Q4 2021.
  • 343 funds tracked by Wall St. Rank held Neogen as of Q4 2024.

Based on Congress Wealth Management's 13F filing for Q4 2024, filed 11 Feb 2025.